Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 9Unknown 4Terminated 4Recruiting 3Not yet recruiting 2

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Cancer Metastatic to Liver 1Choledocholithiasis 1Cholangitis, Sclerosing 1Cholangiocarcinoma 1Biliary Fistula 1

Interventions

Oxaliplatin 86Bevacizumab 66Capecitabine 65Fluorouracil 48tislelizumab 41Gemcitabine 40Drug Therapy 39Leucovorin 38sintilimab 35Irinotecan 34lenvatinib 27Cisplatin 27HMPL-013 25S 1 (combination) 23camrelizumab 22Immune Checkpoint Inhibitors 21irinotecan sucrosofate 20apatinib 20Surgical Procedures, Operative 20Radiotherapy 20Injections 20130-nm albumin-bound paclitaxel 19toripalimab 18Paclitaxel 18Folfox protocol 17pembrolizumab 15Immunotherapy 15Cetuximab 15Specimen Handling 14regorafenib 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Cholangiopancreatography, Endoscopic Retrograde × Gastrointestinal × Clear all
NCT07191418 2026-03-06

Spearmint

Region Västerbotten

Phase NA Not yet recruiting
178 enrolled
Gastrointestinal

Pancreatic Cancer Metastatic to Liver

NCT06670547 2024-11-01

Spanish Registry of Quality Indicators and Adverse Events of Endoscopic Retrograde Cholangiopancreatography

Germans Trias i Pujol Hospital

Not yet recruiting
3,000 enrolled
Gastrointestinal

Biliary Fistula, Cholangitis, Sclerosing, Cholangiocarcinoma, Choledocholithiasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡